基本信息 产品详情 公司简介 推荐产品
网站主页 ZGPAT抗体 ZGPAT抗体
  • ZGPAT抗体
  • ZGPAT抗体
  • ZGPAT抗体

1/3

ZGPAT抗体

Rabbit Polyclonal ZGPAT Antibody
询价 20μl 起订
50μl 起订
100μl 起订
湖北 更新日期:2025-05-14

湖北瑞和宁生物科技有限公司

VIP1年
联系人:周经理
电话:027-19371278702拨打
手机:18008634902 拨打
邮箱:19384116026@163.com

产品详情:

中文名称:
ZGPAT抗体
英文名称:
Rabbit Polyclonal ZGPAT Antibody
品牌:
艾普蒂
产地:
武汉
保存条件:
Stored at -20°C for 5038 year. Avoid repeated freeze / thaw cycles.
产品类别:
抗体
重组:
应用:
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性:
Human,Mouse,Rat
宿主:
Rabbit
偶联物:
靶点:
ZGPAT

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/50-1/300 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/5000-1/10000 Human,Mouse,Rat
   

产品详情

AliasesZIP; ZC3H9; GPATC6; GPATCH6; ZC3HDC9; KIAA1847
WB Predicted band size57 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenFusion protein of human ZGPAT
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane 1-4: Human fetal liver tissue, LO2 cell, PC-3 cell, HEPG2 cell lysates, Primary antibody: P09761(ZGPAT Antibody) at dilution 1/400, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 2 minutes    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human ovarian cancer tissue using P09761(ZGPAT Antibody) at dilution 1/55. (Original magnification: ×200)    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using P09761(ZGPAT Antibody) at dilution 1/55. (Original magnification: ×200)    


           

参考文献

以下是关于ZGPAT抗体的3篇示例文献(注:以下内容为模拟生成,实际文献需通过学术数据库验证):

---

1. **文献名称**: *ZGPAT is a novel epigenetic regulator involved in transcriptional repression*

**作者**: Zhang Y, et al.

**摘要**: 本研究利用ZGPAT抗体进行染色质免疫沉淀(ChIP)实验,发现ZGPAT通过结合靶基因启动子区域的特定序列招募HDAC复合物,抑制组蛋白乙酰化并下调基因表达,影响细胞增殖和分化。

2. **文献名称**: *ZGPAT-mediated DNA damage response in human cells*

**作者**: Wang L, et al.

**摘要**: 通过Western blot和免疫荧光实验(使用ZGPAT抗体),证明ZGPAT在DNA双链断裂修复中与ATM激酶相互作用,其磷酸化修饰对修复通路的激活至关重要。

3. **文献名称**: *ZGPAT antibody-based analysis of liver fibrosis progression*

**作者**: Li X, et al.

**摘要**: 采用ZGPAT抗体对肝组织样本进行免疫组化分析,发现ZGPAT在肝星状细胞中高表达,并通过调控TGF-β信号通路促进纤维化,提示其作为肝病治疗靶点的潜力。

---

**建议**:具体文献请通过PubMed/Google Scholar以“ZGPAT antibody”或“ZGPAT (gene symbol)”为关键词检索,并结合实验场景(如WB/IF/IHC)筛选相关研究。

       

背景信息

ZGPAT (Zinc Finger and G-Patch Domain-Containing Protein) is a nuclear protein encoded by the *ZGPAT* gene in humans. It contains conserved zinc finger motifs and a G-patch domain, suggesting roles in nucleic acid binding and protein interactions. ZGPAT is implicated in transcriptional regulation, chromatin remodeling, and DNA damage response pathways. Studies indicate it may act as a repressor by recruiting histone deacetylases (HDACs) to modulate gene expression, particularly at telomeric regions and repetitive DNA sequences.

ZGPAT antibodies are essential tools for investigating its expression, localization, and molecular functions. They enable detection via techniques like Western blotting, immunofluorescence, and chromatin immunoprecipitation (ChIP). Research using these antibodies has linked ZGPAT to cellular processes such as apoptosis, cell cycle control, and genome stability. Dysregulation of ZGPAT has been observed in certain cancers and autoimmune disorders, highlighting its potential relevance in disease mechanisms.

While ZGPAT's full biological significance remains under exploration, its conserved domains and nuclear activity position it as a critical player in epigenetic regulation. Antibodies against ZGPAT continue to support studies aiming to unravel its interactions with HDAC complexes, telomere-associated proteins, and other regulatory factors, offering insights into its role in health and disease.

       
ZGPAT抗体;ZGPAT;ZGPAT Antibody;

公司简介

湖北瑞和宁生物科技有限公司研究创新能力, 拥有完整、科学、质量管理体系。并不断致力于技术创新,产品创新和管理创新,赢得了国内外广大用户的信任。

成立日期 (2年)
注册资本 50万(元)
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 中间体,化学试剂

ZGPAT抗体相关厂家报价

  • 抗CRF抗体
  • 抗CRF抗体
  • 维百奥(北京)生物科技有限公司 VIP
  • 2025-12-29
  • 询价
内容声明
拨打电话 立即询价